LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
LMSP05000005
|
Galalpha1-6Glcbeta-Cer(t18:0/21:0(2OH[R])
|
1-O-melibiosoyl-(N-(2R-hydroxy-heneicosanoyl)-4R-hydroxy-sphinganine)
|
|
C51H99NO15
|
965.701474
|
LMSP05000006
|
Galalpha1-6Glcbeta-Cer(t18:0/23:0(2OH[R])
|
1-O-melibiosoyl-(N-(2R-hydroxy-tricosanoyl)-4R-hydroxy-sphinganine)
|
|
C53H103NO15
|
993.732774
|
LMSP05000007
|
Galalpha1-6Glcbeta-Cer(t18:0/23:0(2OH[R])
|
1-O-melibiosoyl-(N-(2R-hydroxy-tricosanoyl)-4R-hydroxy-16-methyl-heptasphinganine)
|
|
C53H103NO15
|
993.732774
|
LMSP05000008
|
Galalpha1-6Glcbeta-Cer(t18:0/22:0(2OH[R])
|
1-O-melibiosoyl-(N-(2R-hydroxy-docosanoyl)-4R-hydroxy-16-methyl-heptasphinganine)
|
|
C52H101NO15
|
979.717124
|
LMSP05000009
|
Galalpha1-6Glcbeta-Cer(t18:0/21:0(2OH[R])
|
1-O-melibiosoyl-(N-(2R-hydroxy-heneicosanoyl)-4R-hydroxy-16-methyl-heptasphinganine)
|
|
C51H99NO15
|
965.701474
|
LMSP05000010
|
Galalpha1-6Glcbeta-Cer(t19:0/22:0(2OH[R])
|
1-O-melibiosoyl-(N-(2R-hydroxy-docosanoyl)-4R-hydroxy-17-methyl-sphinganine)
|
|
C53H103NO15
|
993.732774
|
LMSP05000011
|
Galalpha1-6Glcbeta-Cer(t19:1/22:0(2OH[R])
|
1-O-melibiosoyl-(N-(2R-hydroxy-docosanoyl)-4R-hydroxy-17-methyl-sphing-6E-enine)
|
|
C52H99NO15
|
977.701474
|
LMSP05000012
|
Galalpha1-6Glcbeta-Cer(t19:1/21:0(2OH[R])
|
1-O-melibiosoyl-(N-(2R-hydroxy-heneicosanoyl)-4R-hydroxy-17-methyl-sphing-6E-enine)
|
|
C51H97NO15
|
963.685824
|
LMSP05000013
|
Galalpha1-6Glcbeta-Cer(t19:1/21:0(2OH[R])
|
1-O-melibiosoyl-(N-(2R-hydroxy-heneicosanoyl)-4R-hydroxy-16-methyl-sphing-6E-enine)
|
|
C51H97NO15
|
963.685824
|
LMSP05000014
|
Galalpha1-6Glcbeta-Cer(t19:1/22:0(2OH[R])
|
1-O-melibiosoyl-(N-(2R-hydroxy-docosanoyl)-4R-hydroxy-16-methyl-sphing-6E-enine)
|
|
C52H99NO15
|
977.701474
|
LMSP05000015
|
Galalpha1-6Glcbeta-Cer(t19:0/22:0(2OH[R])
|
1-O-melibiosoyl-(N-(2R-hydroxy-docosanoyl)-4R-hydroxy-16-methyl-sphinganine)
|
|
C52H101NO15
|
979.717124
|
LMSP01080080
|
Plakoside B
|
|
|
C59H107NO9
|
973.794584
|
LMSP02030084
|
Stylissamide A
|
N-(2R-hydoxy-pentadecanoyl)-4R-hydroxy-heptadecasphinganine
|
Cer 32:0;O4
|
C32H65NO5
|
543.486274
|
LMSP05010154
|
Stylissoside A
|
N-(2R-hydoxy-heneicosanoyl)-4R-hydroxy-nonadecasphinganine
|
HexCer 40:0;O4
|
C46H91NO10
|
817.664299
|
LMSP05010155
|
Flavuside A
|
N-(2R-hydroxy-octadecanoyl)-1-beta-glucosyl-10-methyl-sphinga-4E,9E-dienine
|
HexCer 37:2;O3
|
C43H81NO9
|
755.591134
|
LMSP05010156
|
Flavuside B
|
N-(2R-hydroxy-3E-octadecenoyl)-1-beta-glucosyl-10-methyl-sphinga-4E,9E-dienine
|
HexCer 37:3;O3
|
C43H79NO9
|
753.575484
|
LMSP01080081
|
Calyxoside
|
(2S,27S-Diamino-3R,26S-dihydroxy-18-oxooctacosyl)beta-D-glucopyranoside
|
|
C34H68N2O9
|
648.492483
|
LMSP01080082
|
Calyxoside B
|
(2S,27S-Diamino-3R,26S-dihydroxy-18-oxooctacosyl)beta-D-galactopyranoside
|
|
C34H68N2O9
|
648.492483
|
LMSP05010157
|
Oreacerebroside A
|
N-(2R-hydroxy-docosanoyl)-1-beta-D-glucosyl-sphing-4E,8E,10E-trienine
|
HexCer 40:3;O3
|
C46H85NO9
|
795.622434
|
LMSP05010158
|
Oreacerebroside D
|
N-(2R-hydroxy-docosanoyl)-1-beta-D-galactosyl-sphing-4E,8E,10E-trienine
|
HexCer 40:3;O3
|
C46H85NO9
|
795.622434
|
LMSP05010159
|
Oreacerebroside E
|
N-(2R-hydroxy-tricosanoyl)-1-beta-D-galactosyl-sphing-4E,8E,10E-trienine
|
HexCer 41:3;O3
|
C47H87NO9
|
809.638084
|
LMSP05010160
|
Oreacerebroside B
|
N-(2R-hydroxy-tricosanoyl)-1-beta-D-glucosyl-sphing-4E,8E,10E-trienine
|
HexCer 41:3;O3
|
C47H87NO9
|
809.638084
|
LMSP05010161
|
Oreacerebroside C
|
N-(2R-hydroxy-tetracosanoyl)-1-beta-D-glucosyl-sphing-4E,8E,10E-trienine
|
HexCer 42:3;O3
|
C48H89NO9
|
823.653734
|
LMSP05010162
|
Oreacerebroside F
|
N-(2R-hydroxy-tetracosanoyl)-1-beta-D-galactosyl-sphing-4E,8E,10E-trienine
|
HexCer 42:3;O3
|
C48H89NO9
|
823.653734
|
LMSP05010163
|
Oreacerebroside I
|
N-(2R-hydroxy-tetracosanoyl)-1-beta-D-galactosyl-9-methyl-sphing-4E,8E,10E-trienine
|
HexCer 43:3;O3
|
C49H91NO9
|
837.669384
|
LMSP05010164
|
Oreacerebroside H
|
N-(2R-hydroxy-tricosanoyl)-1-beta-D-galactosyl-9-methyl-sphing-4E,8E,10E-trienine
|
HexCer 42:3;O3
|
C48H89NO9
|
823.653734
|
LMSP05010165
|
Oreacerebroside G
|
N-(2R-hydroxy-docosanoyl)-1-beta-D-galactosyl-9-methyl-sphing-4E,8E,10E-trienine
|
HexCer 41:3;O3
|
C47H87NO9
|
809.638084
|
LMSP05010166
|
Ophidiacerebroside C
|
N-(2R-hydroxy-docosanoyl)-1-beta-D-glucosyl-9-methyl-sphing-4E,8E,10E-trienine
|
HexCer 41:3;O3
|
C47H87NO9
|
809.638084
|
LMSP05010167
|
Ophidiacerebroside D
|
N-(2R-hydroxy-tricosanoyl)-1-beta-D-glucosyl-9-methyl-sphing-4E,8E,10E-trienine
|
HexCer 42:3;O3
|
C48H89NO9
|
823.653734
|
LMSP05010168
|
Ophidiacerebroside E
|
N-(2R-hydroxy-tetracosanoyl)-1-beta-D-glucosyl-9-methyl-sphing-4E,8E,10E-trienine
|
HexCer 43:3;O3
|
C49H91NO9
|
837.669384
|
LMSP05010169
|
Ophidiacerebroside B
|
N-(2R-hydroxy-heneicosanoyl)-1-beta-D-glucosyl-9-methyl-sphing-4E,8E,10E-trienine
|
HexCer 40:3;O3
|
C46H85NO9
|
795.622434
|
LMSP05010170
|
Ophidiacerebroside A
|
N-(2R-hydroxy-eicosanoyl)-1-beta-D-glucosyl-9-methyl-sphing-4E,8E,10E-trienine
|
HexCer 39:3;O3
|
C45H83NO9
|
781.606784
|
LMSP05010171
|
|
N-(2R-hydroxy-heptadecanoyl)-1-beta-D-glucosyl-9-methyl-sphing-4E,8E,10E-trienine
|
HexCer 36:3;O3
|
C42H77NO9
|
739.559834
|
LMSP05010172
|
|
N-(2R-hydroxy-octadecanoyl)-1-beta-D-glucosyl-9-methyl-sphing-4E,8E,10E-trienine
|
HexCer 37:3;O3
|
C43H79NO9
|
753.575484
|
LMSP05010173
|
Renieroside A1
|
N-(2R-hydroxy-21Z-octacosenoyl)-1-beta-D-glucosyl-sphing-4E,8E,10E-trienine
|
HexCer 46:4;O3
|
C52H95NO9
|
877.700684
|
LMSP05010174
|
Renieroside A2
|
N-(2R-hydroxy-17Z-hexacosenoyl)-1-beta-D-glucosyl-sphing-4E,8E,10E-trienine
|
HexCer 44:4;O3
|
C50H91NO9
|
849.669384
|
LMSP05010175
|
Renieroside A3
|
N-(2R-hydroxy-16Z-pentacosenoyl)-1-beta-D-glucosyl-sphing-4E,8E,10E-trienine
|
HexCer 43:4;O3
|
C49H89NO9
|
835.653734
|
LMSP05010176
|
Renieroside B1
|
N-(2R-hydroxy-21Z-octacosenoyl)-1-beta-D-glucosyl-9-methyl-sphing-4E,8E,10E-trienine
|
HexCer 47:4;O3
|
C53H97NO9
|
891.716334
|
LMSP05010177
|
Renieroside B2
|
N-(2R-hydroxy-17Z-hexacosenoyl)-1-beta-D-glucosyl-9-methyl-sphing-4E,8E,10E-trienine
|
HexCer 45:4;O3
|
C51H93NO9
|
863.685034
|
LMSP05010178
|
Renieroside B3
|
N-(2R-hydroxy-20Z-heptacosenoyl)-1-beta-D-glucosyl-9-methyl-sphing-4E,8E,10E-trienine
|
HexCer 46:4;O3
|
C52H95NO9
|
877.700684
|
LMSP00000021
|
Sulfobacin SL3
|
(2R,3R)-3-Hydroxy-15-methyl-2-[(2-oxo-13-methyltetradecanoyl)amino]-1-hexadecanesulfonic acid
|
|
C33H65NO6S
|
603.453261
|
LMSP00000023
|
Sulfobacin SL8
|
(2S,4E)-3-Hydroxy-2-[(2-hydroxy-13-methyltetradecanoyl)amino]-15-methyl-4-hexadecene-1-sulfonic acid
|
|
C32H63NO6S
|
589.437611
|
LMSP00000024
|
Sulfobacin A
|
(2R,3R,4E)-3-Hydroxy-2-(palmitoylamino)-4-octadecene-1-sulfonic acid
|
|
C34H67NO6S
|
617.468911
|
LMSP00000020
|
Sulfobacin B
|
(2R,3R)-3-Hydroxy-15-methyl-2-[(13-methyltetradecanoyl)amino]-1-hexadecanesulfonic acid
|
|
C33H67NO5S
|
589.473996
|
LMSP00000025
|
(2S,3R,4E,8E)-3-Hydroxy-2-[methyl(stearoyl)amino]-4,8-octadecadien-1-yl hydrogen sulfate
|
(2S,3R,4E,8E)-3-Hydroxy-2-[methyl(stearoyl)amino]-4,8-octadecadien-1-yl hydrogen sulfate
|
|
C37H71NO6S
|
657.500211
|
LMSP07000001
|
Psychosine
|
1-beta-galactosyl-sphing-4-enine
|
|
C24H47NO7
|
461.335254
|
LMSP05010179
|
Agelasphin-9b
|
N-(2S-hydroxy-tetracosanoyl)-1-alpha-galactosyl-16-methyl-heptdecasphinganine
|
HexCer 42:0;O4
|
C48H95NO10
|
845.695599
|
LMSP05010180
|
Agelasphin-9a
|
N-(2S-hydroxy-tetracosanoyl)-1-alpha-galactosyl-heptadecasphinganine
|
HexCer 41:0;O4
|
C47H93NO10
|
831.679949
|
LMSP05010181
|
Agelasphin-7a
|
N-(2S-hydroxy-tetracosanoyl)-1-alpha-galactosyl-hexadecasphinganine
|
HexCer 40:0;O4
|
C46H91NO10
|
817.664299
|
LMSP05010182
|
Agelasphin-7a
|
N-(2S-hydroxy-tetracosanoyl)-1-alpha-galactosyl-16-methyl-octadecasphinganine
|
HexCer 43:0;O4
|
C49H97NO10
|
859.711249
|